Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission

• Richard Carvajal,
• Shaheer Khan,
• Tejus Satish,
• Matt Levin,
• Angela J Yoon

Affiliations

Richard Carvajal

2 Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York, USA

Shaheer Khan

2 Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York, USA

Tejus Satish

1 Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA

Matt Levin

3 Cell IDx, San Diego, California, USA

Angela J Yoon

4 Division of Oral and Maxillofacial Pathology, Columbia University Irving Medical Center, New York, New York, USA